Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Gaudium IVF and Women Health Limited (NSE: GAUDIUMIVF), ISIN INE0P8B01020 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
GAUDIUMIVF last traded at ₹106.45 (+2.18%), with a 52-week range of ₹69.18 to ₹163.18 (as of 6 Nov 2026).
Shareholding as of Sep 2026: promoters 71.29%, FIIs 1.19%, DIIs 2.22%, mutual funds 0.00%.
EquiSense Score (ECS): 25/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.